The US Bankruptcy Court gave an order approving the sale of certain assets of Novan, Inc. on September 12, 2023. The debtor has been authorized to sell its certain assets to Mayne Pharma LLC, the winning bidder at the auction, for a purchase price of $8 million in cash with an earnest money deposit of $0.8 million. The debtor?s assets include certain Commercial Assets.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | 0.00% | 0.00% | +60.00% |
Jan. 17 | First Amended Combined Liquidation Plan and Disclosure Statement Filed by NVN Liquidation, Inc. | CI |
2023 | Modified Disclosure Statement Approved on Interim Basis for NVN Liquidation, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
+60.00% | 22.41K | |
+137.37% | 5.68B | |
+1.89% | 1.01B | |
+2.19% | 982M | |
+41.91% | 872M | |
+25.27% | 819M | |
+1.68% | 663M | |
+0.54% | 610M | |
-.--% | 600M | |
+21.31% | 552M |
- Stock Market
- Equities
- NOVNQ Stock
- News NVN Liquidation, Inc.
- Motion for Asset Sale Approved for Novan, Inc.